Indonesia Urges Greater Transparency in Cross-Border Copyright Royalty Governance Before 35 Countries 
SaunaKits.com Opens Its Upstate South Carolina Showroom, Bringing Hands-On Sauna Shopping to the Southeast 
Encore Construction Shares Guidance to Help Homeowners Avoid Costly Water Damage Insurance Claim Mistakes Vistin Pharma ASA: Second quarter and first half 2021 financial results
Oslo, Norway, 19th of August 2021 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces…
Junshi and Coherus Biosciences Announce Positive Interim Results of CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer
– Toripalimab plus chemotherapy met primary endpoint with significant improvement in PFS compared to chemotherapy…
Eve & Co. Announces Revenues of $4.0M in the First Half of 2021 and Financial Results for the Six Months Ended June 30, 2021
STRATHROY, Ontario, Aug. 18, 2021 (GLOBE NEWSWIRE) — Eve & Co Incorporated (“Eve & Co”,…
Telix Expands Prostate Cancer Activity with GenesisCare Collaboration
MELBOURNE, Australia, Aug. 18, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the…
Coherus and Junshi Biosciences Announce Positive Interim Results of CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer
– Toripalimab plus chemotherapy met primary endpoint with significant improvement in PFS compared to chemotherapy…
Paratek Pharmaceuticals Announces FDA Orphan Drug Designation for NUZYRA® (omadacycline) for the Treatment of Infections Caused by Nontuberculous Mycobacteria
BOSTON, Aug. 18, 2021 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical…
Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., Aug. 18, 2021 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (Nasdaq: MRSN), a clinical-stage…
Bioasis Technologies Inc. Announces the Appointment of Shadow Lake Group as Business Development Advisor
NEW HAVEN, Conn., Aug. 18, 2021 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the…
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
WATERTOWN, Mass., Aug. 18, 2021 (GLOBE NEWSWIRE) — Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that…
Roche receives FDA approval for first companion diagnostic to identify dMMR solid tumour patients eligible for anti-PD-1 immunotherapy
Cancer is the second leading cause of death worldwide, with nearly 10 million deaths annually.1,…
Bavarian Nordic to Host First Half 2021 Results Conference Call and Webcast
COPENHAGEN, Denmark – August 18, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) will…
ProMIS Neurosciences Inc. Announces Upsize of Previously Announced Public Offering of Units to US$17.5M
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Aug….
Cosmos Holdings Announces Voluntary Conversion of Debt to Equity by the Company’s Senior Lender, Further Enhancing the Balance Sheet
CHICAGO, Aug. 18, 2021 (GLOBE NEWSWIRE) — Cosmos Holdings, Inc. (“the Company”) (OTCQX: COSM), an…
Better Choice Company Increases Term-Loan Credit Facility Capacity to $7.5 Million at LIBOR Plus 250 Basis Points
Expanded Facility Capacity Provides Additional Growth Working Capital Availability at Low Cost of Capital NEW…
Global Cell & Gene Therapy Sector on Pace for Annual Records in Product Approvals and Financings, Says Alliance for Regenerative Medicine
GLOBAL CELL & GENE THERAPY SECTOR ON PACE FOR ANNUAL RECORDS IN PRODUCT APPROVALS AND…
Digipath Announces Results for Third Fiscal Quarter 2021
Third Quarter Revenues Increased by 88% Compared to the Same Period Last Year LAS VEGAS,…
Codiak BioSciences Appoints Lini Pandite, MBChB, MBA to Board of Directors
CAMBRIDGE, Mass., Aug. 18, 2021 (GLOBE NEWSWIRE) — Codiak BioSciences, Inc. (Nasdaq: CDAK), a clinical-stage…
Galecto Announces First Patient Treated in Phase 2a Trial of the Oral LOXL2 Inhibitor GB2064 in Myelofibrosis (the MYLOX-1 Trial)
BOSTON, Aug. 18, 2021 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a biotechnology company focused…
AGTC Appoints Ophthalmology and Retinal Disease Specialist and Industry R&D Veteran Yehia Hashad, MD to its Board of Directors
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Aug. 18, 2021 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation…
Assembly Bio Selects Fourth HBV Core Inhibitor Candidate for Advancement Into Clinical Development
SOUTH SAN FRANCISCO, Calif., Aug. 18, 2021 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. (Nasdaq: ASMB),…